05-23-2407 | Calcitonin Gene-Related Peptide-I 8-37, Human

05-23-2407
  
Retrieving price...
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service

       

      Contact Customer Service

      Click To Print This Page

      Overview

      Replacement Information

      Key Spec Table

      Empirical FormulaCAS #
      C₁₃₉H₂₃₀N₄₄O₃₈ 119911-68-1
      Description
      Overview

      This product has been discontinued.

      We are offering Calcitonin Gene-Related Peptide I, Human (Cat. No. 05-23-2404) as a possible alternative. Please read the alternative product documentation carefully and contact technical service if you need additional information.





      Competitive antagonist of CGRP receptor with vasoconstrictive properties.
      Catalogue Number05-23-2407
      Brand Family Calbiochem®
      SynonymsCGRP-I 8-37, VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH₂
      References
      ReferencesNuki, C., et al. 1994. Jpn. J. Pharmacol. 65, 99. Gardiner, A.M., et al. 1990. Biochem. Biophys. Res. Commun. 171, 938. Han, S.-P., et al. 1990. Biochem. Biophys. Res. Commun. 168, 786. Chiba, T., et al. 1989. Am. J. Physiol. 256, E331.
      Product Information
      CAS number119911-68-1
      FormWhite solid
      Hill FormulaC₁₃₉H₂₃₀N₄₄O₃₈
      Chemical formulaC₁₃₉H₂₃₀N₄₄O₃₈
      Hygroscopic Hygroscopic
      Sold on the basis of peptide contentY
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Peptide ContentY
      Peptide SequenceH-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      MSDS

      Title

      Safety Data Sheet (SDS) 

      Certificates of Analysis

      TitleLot Number
      05-23-2407

      References

      Reference overview
      Nuki, C., et al. 1994. Jpn. J. Pharmacol. 65, 99. Gardiner, A.M., et al. 1990. Biochem. Biophys. Res. Commun. 171, 938. Han, S.-P., et al. 1990. Biochem. Biophys. Res. Commun. 168, 786. Chiba, T., et al. 1989. Am. J. Physiol. 256, E331.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-September-2008 RFH
      SynonymsCGRP-I 8-37, VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH₂
      DescriptionCompetitive antagonist of CGRP receptor.
      FormWhite solid
      Recommended reaction conditionshttp://www.emdbiosciences.com/products/EMD_BIO-
      CAS number119911-68-1
      Chemical formulaC₁₃₉H₂₃₀N₄₄O₃₈
      Peptide SequenceH-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH₂
      Purity≥97% by HPLC
      Solubility5% Acetic acid (1 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Standard Handling
      ReferencesNuki, C., et al. 1994. Jpn. J. Pharmacol. 65, 99. Gardiner, A.M., et al. 1990. Biochem. Biophys. Res. Commun. 171, 938. Han, S.-P., et al. 1990. Biochem. Biophys. Res. Commun. 168, 786. Chiba, T., et al. 1989. Am. J. Physiol. 256, E331.